<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(3)</volume><submitter>Zhou S</submitter><pubmed_abstract>Pathogenic mycobacteria orchestrate the complex cell populations known as granuloma that is the hallmark of tuberculosis. Foam cells, a lipid-rich cell-type, are considered critical for granuloma formation; however, the causative factor in foam cell formation remains unclear. Atherosclerosis is a chronic inflammatory disease characterized by the abundant accumulation of lipid-laden-macrophage-derived foam cells during which cholesterol 25-hydroxylase (CH25H) is crucial in foam cell formation. Here, we show that &lt;i>M&lt;/i>. &lt;i>marinum&lt;/i> (&lt;i>Mm&lt;/i>), a relative of &lt;i>M&lt;/i>. &lt;i>tuberculosis&lt;/i>, induces foam cell formation, leading to granuloma development following CH25H upregulation. Moreover, the &lt;i>Mm&lt;/i>-driven increase in CH25H expression is associated with the presence of phthiocerol dimycocerosate, a determinant for &lt;i>Mm&lt;/i> virulence and integrity. CH25H-&lt;i>null&lt;/i> mice showed decreased foam cell formation and attenuated pathology. Atorvastatin, a recommended first-line lipid-lowering drug, promoted the elimination of &lt;i>M. marinum&lt;/i> and concomitantly reduced CH25H production. These results define a previously unknown role for CH25H in controlling macrophage-derived foam cell formation and Tuberculosis pathology.</pubmed_abstract><journal>iScience</journal><pagination>109204</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10901098</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Pathogenic mycobacterium upregulates cholesterol 25-hydroxylase to promote granuloma development via foam cell formation.</pubmed_title><pmcid>PMC10901098</pmcid><pubmed_authors>Xia X</pubmed_authors><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Ding C</pubmed_authors><pubmed_authors>Zhou S</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Han S</pubmed_authors><pubmed_authors>Jin Z</pubmed_authors><pubmed_authors>Song J</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors><pubmed_authors>Huang W</pubmed_authors><pubmed_authors>Yan B</pubmed_authors><pubmed_authors>Gonzales J</pubmed_authors><pubmed_authors>Via LE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pathogenic mycobacterium upregulates cholesterol 25-hydroxylase to promote granuloma development via foam cell formation.</name><description>Pathogenic mycobacteria orchestrate the complex cell populations known as granuloma that is the hallmark of tuberculosis. Foam cells, a lipid-rich cell-type, are considered critical for granuloma formation; however, the causative factor in foam cell formation remains unclear. Atherosclerosis is a chronic inflammatory disease characterized by the abundant accumulation of lipid-laden-macrophage-derived foam cells during which cholesterol 25-hydroxylase (CH25H) is crucial in foam cell formation. Here, we show that &lt;i>M&lt;/i>. &lt;i>marinum&lt;/i> (&lt;i>Mm&lt;/i>), a relative of &lt;i>M&lt;/i>. &lt;i>tuberculosis&lt;/i>, induces foam cell formation, leading to granuloma development following CH25H upregulation. Moreover, the &lt;i>Mm&lt;/i>-driven increase in CH25H expression is associated with the presence of phthiocerol dimycocerosate, a determinant for &lt;i>Mm&lt;/i> virulence and integrity. CH25H-&lt;i>null&lt;/i> mice showed decreased foam cell formation and attenuated pathology. Atorvastatin, a recommended first-line lipid-lowering drug, promoted the elimination of &lt;i>M. marinum&lt;/i> and concomitantly reduced CH25H production. These results define a previously unknown role for CH25H in controlling macrophage-derived foam cell formation and Tuberculosis pathology.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-22T06:39:59.371Z</modification><creation>2025-04-05T21:49:10.025Z</creation></dates><accession>S-EPMC10901098</accession><cross_references><pubmed>38420591</pubmed><doi>10.1016/j.isci.2024.109204</doi></cross_references></HashMap>